TRXBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
TRex Bio, Inc.
$14.80+0.79 (+5.64%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About TRex Bio
Biological Products, (No Diagnostic Substances), SIC 2836
TRex Bio, Inc. is listed on Nasdaq under the ticker TRXB, in the SEC industry Biological Products, (No Diagnostic Substances). It is incorporated in Delaware and its fiscal year ends on December 31.
Company profile
Company
- Legal name
- TRex Bio, Inc.
- Headquarters
- South San Francisco, CA
- Address
- C/O Trex Bio, Inc., 269 East Grand Avenue Suite 300
- Phone
- (650) 567-5582
- Website
- trex.bio
- Industry
- Biological Products, (No Diagnostic Substances)
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- TRXB
- Exchange
- Nasdaq
- IPO date
- Oct 9, 2026
- Filer category
- <br>Emerging growth company
- SEC CIK
- 2139097
- CUSIP
- 89531N100
- ISIN
- US89531N1000
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
TRex Bio's leadership is listed in its proxy statement (Form DEF 14A).
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 9, 2026 | IPO | Initial public offering priced (424B4 prospectus) |
| Oct 6, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |